Kornitzer Capital Management Inc. KS boosted its position in shares of STAAR Surgical (NASDAQ:STAA) by 77.3% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 292,550 shares of the medical instruments supplier’s stock after acquiring an additional 127,525 shares during the period. Kornitzer Capital Management Inc. KS owned 0.66% of STAAR Surgical worth $8,595,000 as of its most recent SEC filing.

A number of other large investors have also recently modified their holdings of the stock. KAMES CAPITAL plc purchased a new position in STAAR Surgical in the 2nd quarter worth approximately $3,366,000. Gilder Gagnon Howe & Co. LLC boosted its stake in shares of STAAR Surgical by 418.9% in the 1st quarter. Gilder Gagnon Howe & Co. LLC now owns 119,869 shares of the medical instruments supplier’s stock valued at $4,098,000 after purchasing an additional 96,768 shares in the last quarter. Dimensional Fund Advisors LP boosted its stake in shares of STAAR Surgical by 162.4% in the 4th quarter. Dimensional Fund Advisors LP now owns 151,780 shares of the medical instruments supplier’s stock valued at $4,843,000 after purchasing an additional 93,940 shares in the last quarter. Roubaix Capital LLC purchased a new stake in shares of STAAR Surgical in the 2nd quarter valued at $2,556,000. Finally, Cortina Asset Management LLC boosted its stake in shares of STAAR Surgical by 47.3% in the 2nd quarter. Cortina Asset Management LLC now owns 268,448 shares of the medical instruments supplier’s stock valued at $7,887,000 after purchasing an additional 86,184 shares in the last quarter. 91.25% of the stock is owned by institutional investors.

NASDAQ:STAA opened at $31.84 on Thursday. The firm’s fifty day moving average price is $31.14. STAAR Surgical has a 52 week low of $21.70 and a 52 week high of $54.00. The company has a quick ratio of 4.97, a current ratio of 5.53 and a debt-to-equity ratio of 0.04. The company has a market cap of $1.42 billion, a price-to-earnings ratio of 113.71 and a beta of 2.24.

STAAR Surgical (NASDAQ:STAA) last posted its quarterly earnings results on Wednesday, July 31st. The medical instruments supplier reported $0.14 EPS for the quarter, beating the Zacks’ consensus estimate of $0.10 by $0.04. STAAR Surgical had a net margin of 5.80% and a return on equity of 12.81%. The company had revenue of $39.66 million during the quarter, compared to analyst estimates of $40.10 million. Research analysts predict that STAAR Surgical will post 0.33 EPS for the current fiscal year.

A number of equities research analysts have recently issued reports on the stock. BidaskClub cut shares of STAAR Surgical from a “buy” rating to a “hold” rating in a research note on Wednesday, August 7th. Canaccord Genuity reaffirmed a “buy” rating and issued a $38.00 price objective (down previously from $43.00) on shares of STAAR Surgical in a research note on Monday, May 6th. Zacks Investment Research cut shares of STAAR Surgical from a “buy” rating to a “hold” rating in a research note on Friday, August 2nd. Finally, ValuEngine raised shares of STAAR Surgical from a “hold” rating to a “buy” rating in a research note on Wednesday, May 1st. Two investment analysts have rated the stock with a hold rating and three have assigned a buy rating to the company’s stock. The stock has a consensus rating of “Buy” and a consensus target price of $42.00.

About STAAR Surgical

STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and delivery systems to deliver the lenses into the eye. The company provides Visian implantable collamer lenses (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia; and Hyperopic ICL, which treats far-sightedness.

See Also: Correction

Want to see what other hedge funds are holding STAA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for STAAR Surgical (NASDAQ:STAA).

Institutional Ownership by Quarter for STAAR Surgical (NASDAQ:STAA)

Receive News & Ratings for STAAR Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for STAAR Surgical and related companies with MarketBeat.com's FREE daily email newsletter.